Qube Research & Technologies LTD Uro Gen Pharma Ltd. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.99 - $11.02 $234,266 - $323,106	29,320 Added 173.56%	46,213 $427,000
Q4 2022 Feb 14, 2023	BUY	$7.55 - $11.96 $27,210 - $43,103	3,604 Added 27.12%	16,893 $149,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.41 $11,925 - $15,564	-1,654 Reduced 11.07%	13,289 $111,000
Q2 2022 Aug 15, 2022	BUY	$5.12 - $8.74 $76,508 - $130,601	14,943 New	14,943 $122,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.